PGAP1 (Post-GPI Attachment to Proteins 1): Gene, Function, and Disease Associations

A comprehensive overview of the PGAP1 gene, its role in GPI anchor remodeling, associated diseases, expression patterns, and mutations.

Gene Information Card

Symbol PGAP1
Full Name post-GPI attachment to proteins 1
Gene Type protein coding
Chromosomal Location 2q33.1
NCBI Gene ID 80055 ncbi.nlm.nih.gov/gene/80055
Ensembl ID ENSG00000157110
UniProt ID Q75T13
OMIM ID 611655
HGNC ID 25712
Aliases FLJ21820, GPI inositol-deacylase

Description

PGAP1 (post-GPI attachment to proteins 1) encodes an enzyme involved in the remodeling of glycosylphosphatidylinositol (GPI) anchors. Specifically, it catalyzes the deacetylation of inositol, a step required for the proper maturation of GPI-anchored proteins. This gene is essential for the correct sorting and function of GPI-anchored proteins, which play roles in cell signaling, adhesion, and immunity. Mutations in PGAP1 are associated with intellectual disability and other neurodevelopmental disorders.

Disease Associations

Disease category Pathophysiological mechanism Genomic evidence
Intellectual disability, autosomal recessive 42 Loss-of-function mutations impair GPI anchor remodeling, leading to defective GPI-anchored protein expression on cell surfaces, affecting neuronal development. OMIM #616589; ClinVar submissions
Hyperphosphatasia with intellectual disability syndrome (HPMRS) (in some cases) Biallelic mutations in PGAP1 cause a phenotype overlapping with HPMRS, characterized by elevated serum alkaline phosphatase and intellectual disability. OMIM #616589; case reports in PubMed
Developmental delay and seizures PGAP1 mutations disrupt GPI anchor biosynthesis, affecting synaptic function and neuronal excitability. ClinVar and literature (e.g., PMID 25356898)

Expression Profile

Tissue Expression
Tissue nTPM level
Brain 12.4 Medium
Testis 8.9 Low
Kidney 7.2 Low
Liver 5.1 Low
Lung 4.3 Low
Cell Line Expression
Cell Line nTPM Notes
HEK 293 10.5 Embryonic kidney cells; moderate expression
HeLa 8.2 Cervical carcinoma; moderate expression
K562 6.7 Leukemia; low expression
HepG2 5.9 Liver carcinoma; low expression
Data source:Human Protein Atlas(proteinatlas.org)

Mutations & Variants

Hotspot Mutations
Variant Type Frequency Functional Description
c.1045C>T (p.Arg349Ter) Nonsense Rare Loss of function; premature truncation
c.1576G>A (p.Gly526Arg) Missense Rare Likely damaging; affects enzyme activity
c.2002delC (p.Leu668TrpfsTer3) Frameshift Rare Loss of function; truncated protein
Mutation functional classification

Loss of Function (LOF)

Most PGAP1 mutations are loss-of-function, leading to reduced or absent deacylase activity, impairing GPI anchor remodeling and causing disease.

Gain of Function (GOF)

No gain-of-function mutations have been reported for PGAP1.

Dominant Negative (DN)

No dominant-negative effects have been documented; PGAP1 mutations are typically recessive.

Gene Ontology (GO)

• GPI inositol-deacylase activity • hydrolase activity
• membrane • GPI-anchor biosynthetic process
• protein glycosylation

Pathways

• GPI anchor biosynthesis
• Metabolism of proteins
• Post-translational protein modification

Protein Summary

The PGAP1 protein is a transmembrane enzyme localized to the endoplasmic reticulum (ER) and Golgi apparatus. It catalyzes the removal of an acetyl group from the inositol ring of GPI anchors, a critical step in GPI lipid remodeling. This remodeling is necessary for the efficient transport of GPI-anchored proteins to the plasma membrane and for their association with lipid rafts. Defects in PGAP1 lead to abnormal GPI-anchored protein expression, contributing to neurodevelopmental phenotypes.

Related Products

Product name Cat.No. Species Gene ID
PGAP1 Knockout HEK293 Cell Line EDJ-KQ9440 Human 80055 Details Get a Quote
PGAP1 Knockout A-549 Cell Line EDJ-KQ36120 Human 80055 Details Get a Quote
PGAP1 Knockout HCT 116 Cell Line EDJ-KQ36121 Human 80055 Details Get a Quote
PGAP1 Knockout HeLa Cell Line EDJ-KQ36122 Human 80055 Details Get a Quote
Contact Us
*
*
*
How did you hear about us: